Code | 1248D | ||||||||||
MA number | 29/0117/19-S | ||||||||||
Product Form: | tbl flm 8x25 mg (blis.Al/PA/Al/PVC) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | Decentralised | ||||||||||
Therapeutic Class: | 29 - ANTIRHEUMATICA, ANTIPHLOGISTICA, ANTIURATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product not subject to medical prescription. |
Legal basis: | Article 10(3) hybrid application |
MA issued: | 29.04.2019 |
SPC: | SPC_Okitask 25 mg filmom obalené tablety_08.2023.pdf |
PIL: | PIL_Okitask 25 mg filmom obalené tablety_08.2023.pdf |
Safety feature | No |
Data update: | 25.10.2023 |